You are here: All Products  > I-Mab Plans to Partner its CD-47 Immunotherapy in $2 Billion Deal

I-Mab Plans to Partner its CD-47 Immunotherapy in $2 Billion Deal

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days